Last reviewed · How we verify
Standard reference therapy
At a glance
| Generic name | Standard reference therapy |
|---|---|
| Sponsor | Johns Hopkins Bloomberg School of Public Health |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Prospective Validation of Ataraxis AI Test for Predicting Treatment Response in Neoadjuvant Breast Cancer
- The Impact of Music Medicine on Preterm Brain Development and Behavior (NA)
- Serial Brain MRI in Hospitalized Preterm Infants (NA)
- Effect of Ambient Temperature on Blood Glucose and Insulin Absorption in Adults With Type 1 Diabetes (NA)
- GNB4 and Riplet Gene Methylation Combined Detection Kit for Hepatocellular Carcinoma Recurrence Monitoring
- Evaluation of a Nurse-led Program for the Prevention of Complications of Long-term Corticosteroid Therapy (NA)
- Feasibility Trial of a Single Session of Crisis Response Planning for Youth at High Risk for Suicide (NA)
- A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: